Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Feb;57(2):139–141. doi: 10.1038/bjc.1988.29

Urinary epidermal growth factor concentrations in various human malignancies.

A L Mattila 1, I Saario 1, L Viinikka 1, O Ylikorkala 1, J Perheentupa 1
PMCID: PMC2246428  PMID: 3258759

Abstract

We determined the concentrations of immunoreactive epidermal growth factor in the urine (U-irEGF) of 97 adult patients with various malignancies, including carcinomas of the urinary bladder, kidney, stomach, colon, rectum, breast, endometrium, uterine cervix, ovary, vagina, prostate, pancreas and thyroid, liposarcoma and skin melanoma. The relative U-irEGF concentrations (ng m-1 creatinine) were higher (P = 0.002) for the whole series of female patients than for healthy controls matched for sex and age. Such difference did not appear for male patients. The only specific group with a statistically supranormal U-irEGF concentration (P = 0.0005) comprised women with endometrial carcinoma of the uterus.

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carpenter G., Zendegui J. G. Epidermal growth factor, its receptor, and related proteins. Exp Cell Res. 1986 May;164(1):1–10. doi: 10.1016/0014-4827(86)90449-0. [DOI] [PubMed] [Google Scholar]
  2. Dailey G. E., Kraus J. W., Orth D. N. Homologous radioimmunoassay for human epidermal growth factor (urogastrone). J Clin Endocrinol Metab. 1978 Jun;46(6):929–936. doi: 10.1210/jcem-46-6-929. [DOI] [PubMed] [Google Scholar]
  3. Downward J., Yarden Y., Mayes E., Scrace G., Totty N., Stockwell P., Ullrich A., Schlessinger J., Waterfield M. D. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature. 1984 Feb 9;307(5951):521–527. doi: 10.1038/307521a0. [DOI] [PubMed] [Google Scholar]
  4. Gambrell R. D., Jr The role of hormones in the etiology and prevention of endometrial cancer. Clin Obstet Gynaecol. 1986 Dec;13(4):695–723. [PubMed] [Google Scholar]
  5. Gospodarowicz D. Epidermal and nerve growth factors in mammalian development. Annu Rev Physiol. 1981;43:251–263. doi: 10.1146/annurev.ph.43.030181.001343. [DOI] [PubMed] [Google Scholar]
  6. Kurobe M., Aono M., Moriga M., Furukawa S., Hayashi K. Assessment by a two-site enzyme immunoassay of human epidermal growth factor (urogastrone) in the urine of patients with various gastrointestinal diseases including malignant tumors. Biochem Int. 1985 Dec;11(6):817–823. [PubMed] [Google Scholar]
  7. Libermann T. A., Razon N., Bartal A. D., Yarden Y., Schlessinger J., Soreq H. Expression of epidermal growth factor receptors in human brain tumors. Cancer Res. 1984 Feb;44(2):753–760. [PubMed] [Google Scholar]
  8. Lin C. R., Chen W. S., Kruiger W., Stolarsky L. S., Weber W., Evans R. M., Verma I. M., Gill G. N., Rosenfeld M. G. Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells. Science. 1984 May 25;224(4651):843–848. doi: 10.1126/science.6326261. [DOI] [PubMed] [Google Scholar]
  9. Lustgarten J. A., Wenk R. E. Simple, rapid, kinetic method for serum creatinine measurement. Clin Chem. 1972 Nov;18(11):1419–1422. [PubMed] [Google Scholar]
  10. Mattila A. L. Human urinary epidermal growth factor: effects of age, sex and female endocrine status. Life Sci. 1986 Nov 17;39(20):1879–1884. doi: 10.1016/0024-3205(86)90298-5. [DOI] [PubMed] [Google Scholar]
  11. Mattila A. L., Pasternack A., Viinikka L., Perheentupa J. Subnormal concentrations of urinary epidermal growth factor in patients with kidney disease. J Clin Endocrinol Metab. 1986 Jun;62(6):1180–1183. doi: 10.1210/jcem-62-6-1180. [DOI] [PubMed] [Google Scholar]
  12. Mattila A. L., Perheentupa J., Pesonen K., Viinikka L. Epidermal growth factor in human urine from birth to puberty. J Clin Endocrinol Metab. 1985 Nov;61(5):997–1000. doi: 10.1210/jcem-61-5-997. [DOI] [PubMed] [Google Scholar]
  13. Merlino G. T., Xu Y. H., Ishii S., Clark A. J., Semba K., Toyoshima K., Yamamoto T., Pastan I. Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science. 1984 Apr 27;224(4647):417–419. doi: 10.1126/science.6200934. [DOI] [PubMed] [Google Scholar]
  14. Perheentupa J., Lakshmanan J., Fisher D. A. Urine and kidney epidermal growth factor: ontogeny and sex difference in the mouse. Pediatr Res. 1985 May;19(5):428–432. doi: 10.1203/00006450-198505000-00004. [DOI] [PubMed] [Google Scholar]
  15. Rall L. B., Scott J., Bell G. I., Crawford R. J., Penschow J. D., Niall H. D., Coghlan J. P. Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature. 1985 Jan 17;313(5999):228–231. doi: 10.1038/313228a0. [DOI] [PubMed] [Google Scholar]
  16. Roberts A. B., Lamb L. C., Newton D. L., Sporn M. B., De Larco J. E., Todaro G. J. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3494–3498. doi: 10.1073/pnas.77.6.3494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sherwin S. A., Twardzik D. R., Bohn W. H., Cockley K. D., Todaro G. J. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer. Cancer Res. 1983 Jan;43(1):403–407. [PubMed] [Google Scholar]
  18. Skov Olsen P., Nexø E., Poulsen S. S., Hansen H. F., Kirkegaard P. Renal origin of rat urinary epidermal growth factor. Regul Pept. 1984 Dec;10(1):37–45. doi: 10.1016/0167-0115(84)90051-x. [DOI] [PubMed] [Google Scholar]
  19. Stoscheck C. M., King L. E., Jr Role of epidermal growth factor in carcinogenesis. Cancer Res. 1986 Mar;46(3):1030–1037. [PubMed] [Google Scholar]
  20. Todaro G. J., Fryling C., De Larco J. E. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5258–5262. doi: 10.1073/pnas.77.9.5258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Twardzik D. R., Sherwin S. A. Transforming growth factor (TGF) activity in human urine: synergism between TGF-beta and urogastrone. J Cell Biochem. 1985;28(4):289–297. doi: 10.1002/jcb.240280407. [DOI] [PubMed] [Google Scholar]
  22. Uchihashi M., Hirata Y., Fujita T., Matsukura S. Age-related decrease of urinary excretion of human epidermal growth factor (hEGF). Life Sci. 1982 Aug 16;31(7):679–683. doi: 10.1016/0024-3205(82)90769-x. [DOI] [PubMed] [Google Scholar]
  23. Uchihashi M., Hirata Y., Nakajima H., Fujita T., Matsukura S. Urinary excretion of human epidermal growth factor (hEGF) in patients with malignant tumors. Horm Metab Res. 1983 May;15(5):261–262. doi: 10.1055/s-2007-1018690. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES